|
Real-time Estimate
Cboe Europe
05:09:22 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 1,524.00 GBX | -0.72% |
|
-4.29% | -0.89% |
| 09-08 | Barclays Upgrades Hikma Pharmaceuticals to Equalweight, Boosts PT | MT |
| 09-08 | WINNERS & LOSERS: Oil up, Dunelm down, Computacenter rises then falls | AN |
| Market Cap | 4.37B 3.76B 3.54B 3.23B 6.04B 416B 6.07B 42B 16.23B 212B 16.42B 16.07B 672B | P/E 2026 * |
11.3x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 5.86B 5.04B 4.75B 4.33B 8.09B 557B 8.12B 56.26B 21.74B 284B 22B 21.52B 900B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 1.58x |
| Free-Float |
63.16% | Yield 2026 * |
4.16% | Yield 2027 * | 4.4% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| HIK | Delayed | |
CBOE
| HIK | Real-time | |
|
Tradegate
| H5P | Real-time | |
|
OTC Markets
| HKMPF | Delayed | |
|
Deutsche Boerse AG
| H5P | Delayed | |
|
Börse Stuttgart
| H5P | Delayed | |
|
Boerse Muenchen
| H5P | Real-time |
Last Transcript : Hikma Pharmaceuticals PLC
| 1 day | -0.33% | ||
| 1 week | -4.29% | ||
| Current month | -4.94% | ||
| 1 month | -6.84% | ||
| 3 months | +5.00% | ||
| 6 months | +28.34% | ||
| Current year | -0.89% |
| 1 week | 1,524 |  | 1,638 |
| 1 month | 1,524 | | 1,673 |
| Current year | 1,187 | | 1,762 |
| 1 year | 1,187 | | 1,865 |
| 3 years | 1,187 | | 2,360 |
| 5 years | 1,174.5 | | 2,546 |
| 10 years | 814.2 | | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 2025-11-30 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 2026-02-25 |
| Chief Tech/Sci/R&D Officer | 64 | 2026-02-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2005-10-13 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 2025-12-14 |
Said Darwazah
CHM | Chairman | 69 | 2014-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/1/26 | Sell | Investor Relations Manager | -26,558 | 0.0124% | ||
| 6/1/26 | Exercice | Director | 72,763 | 0.0339% | ||
| 6/1/26 | Exercice | Director | 20,650 | 0.0096% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | -4.29% | -7.68% | -25.89% | 4.37B | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 644B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 443B | |
| -1.31% | -2.92% | +30.06% | +36.31% | 343B | |
| +1.29% | -13.84% | +12.31% | +28.12% | 262B | |
| -0.23% | -4.01% | -2.14% | +11.02% | 245B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 212B | |
| +0.16% | -4.31% | -17.83% | -57.81% | 199B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 181B | |
| Average | -0.10% | -4.99% | +20.02% | +36.06% | 353.41B | |
| Weighted average by Cap. | -0.11% | -4.24% | +32.17% | +57.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 2.98B 2.8B 2.55B 4.78B 329B 4.8B 33.22B 12.84B 168B 12.99B 12.71B 531B | 3.6B 3.1B 2.92B 2.66B 4.97B 343B 4.99B 34.59B 13.37B 175B 13.52B 13.23B 553B |
| Net income | 412M 355M 334M 304M 569M 39.23B 572M 3.96B 1.53B 19.98B 1.55B 1.51B 63.31B | 453M 390M 367M 335M 626M 43.15B 629M 4.35B 1.68B 21.98B 1.7B 1.67B 69.64B |
| Net Debt | 1.48B 1.28B 1.2B 1.1B 2.05B 141B 2.06B 14.26B 5.51B 71.97B 5.57B 5.45B 228B | 1.31B 1.13B 1.06B 967M 1.81B 125B 1.82B 12.58B 4.86B 63.53B 4.92B 4.81B 201B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | GBX 1,524.00 | -0.72% | 60,729 |
| 26-09-09 | GBX 1,535.00 | -3.82% | 571,231 |
| 26-09-08 | GBX 1,596.00 | -0.25% | 504,097 |
| 26-09-07 | GBX 1,600.00 | +0.44% | 375,580 |
| 26-09-04 | GBX 1,593.00 | -0.75% | 365,452 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions
